Biotechnology company developing first-in-class small-molecule drugs that activate mitochondrial thermogenesis to increase metabolic rate and treat obesity and other metabolic disorders, including type 2 diabetes
Biotechnology company developing first-in-class small-molecule drugs that activate mitochondrial thermogenesis to increase metabolic rate and treat obesity and other metabolic disorders, including type 2 diabetes. Its drug-discovery platform uses high-throughput assays and direct measurement of mitochondrial electrical currents to identify selective, safe activators of mitochondrial heat production.